|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Alveolar macrophages are the preferential site for growth of
Legionella pneumophila (Lp) during infection. However, the study of Lp infection in alveolar macrophages is difficult due to the limitation of available primary alveolar macrophages. In the
present study, we established an in vitro Lp infection model in
alveolar macrophages using a continuous cell line of murine alveolar macrophages designated MH-S. Infection of both MH-S
cells and primary mouse alveolar macrophages obtained by alveolar lavage with virulent L. pneumophila (Lp-V) showed vigorous growth of the bacteria, but infection with avirulent L. pneumophila (Lp-Av) resulted in only minimum growth. Cytokine
message expression determination in the MH-S cells after infection showed strong induction of interluekin (IL)-6, IL-10,
and tumor necrosis factor-
messages induced by Lp-V but
minimal induction of these cytokines by Lp-Av infection. IL-1
protein secretion and the message levels for IL-1
were also
analyzed, and remarkable induction of IL-1
was evident in both
macrophage types when infected with Lp-V. Analysis of IL-12 p40 responses of both macrophage types to Lp-V infection assessed by reverse transcriptase/polymerase chain reaction revealed induction of increased message levels, but significant
levels were induced only slowly. Determination of IL-12 protein secretion by enzyme-linked immunosorbent assay of culture supernatants from both macrophage types infected with
either Lp-V or Lp-Av showed only minimum production. Thus,
MH-S alveolar macrophages showed a similar response to Lp infection compared with primary alveolar macrophages and
can be a useful in vitro model system to study Lp infection. The
study also revealed the restricted IL-12 protein secretion of alveolar macrophages by Lp infection.
| |
Introduction |
|---|
|
|
|---|
Legionella pneumophila (Lp) is a gram-negative, facultative
intracellular pathogen and is the etiologic agent of Legionnaires' disease. Once the bacteria enter the respiratory tract
and cause pneumonia, most of the invading microorganisms
are located within inflammatory phagocytic cells. Alveolar
macrophages are especially thought to be the preferential
site for growth of Lp in human lung tissue (1). The mechanism by which Legionella infection of the lung is controlled
is not yet clear, but the development of cell-mediated immunity (CMI) is essential in host defense to Lp infection.
T helper 1 (Th1) cells are essential for the development of
CMI and may play a pivotal role in the defense against Lp
infection. Interleukin (IL)-12 and the interferon (IFN)-
that is induced by IL-12 from Th1 cells play central roles in
the development of the protective Th1-type immune response
(2). It is known that the Th1 cytokine IFN-
can activate
macrophages and monocytes to inhibit Lp growth (3, 4). In
contrast, other cytokines, including IL-10, facilitate growth
of Lp in permissive mononuclear phagocytes, due in part to
IL-10-mediated inhibition of tumor necrosis factor (TNF)-
secretion and IFN-
-mediated mononuclear phagocyte activation (5). The induction of such key cytokines by alveolar
macrophages is, therefore, considered one of the important immunoregulatory functions of macrophages during the development of T-helper cell phenotypes. However, the induction mechanism of these cytokines by Lp infection in alveolar macrophages is not well understood.
To investigate the in vitro cytokine regulation and induction mechanism of macrophages by Lp infection, previous studies in this laboratory and by others used mainly human monocytes, mouse peritoneal macrophages, and macrophage cell lines that were not derived from the lung (3). However, it has been reported that macrophages obtained from disparate anatomical sites differ functionally and phenotypically (10) and that phenotypically distinct macrophage subpopulations can be identified and isolated from the bronchoalveolar lavage of the human lower respiratory tract (11). The few studies with alveolar macrophages focused only on the growth of Lp in the macrophages (12, 13), and cytokine responses of alveolar macrophages to Lp infection have not been well studied.
MH-S cells are a continuous cell line of murine alveolar macrophages, which were established after transformation of cells obtained by bronchoalveolar lavage from Balb/c mice with simian virus 40 (14). Results of characterization studies of MH-S cells (15) indicated that this cell line may facilitate studies where homogeneous populations of alveolar macrophages are desirable, especially those involved in determining the immunologic responses of alveolar macrophages to Lp infection and their potential role in lung pathology. The necessity of an in vitro alveolar macrophage system to study Lp infection is obvious because the preferential infection site for Lp is the lung and particularly alveolar macrophages, which are the major target cells for Lp infection but functionally and phenotypically different from other tissue macrophages (10, 16, 17). In fact, our previous study showed the immune response of alveolar macrophages to Lp infection is different than that of peritoneal macrophages (18). Thus, establishment of an in vitro alveolar macrophage system is desirable for the successful study of macrophage-Lp interactions. Therefore, in the present study, we attempted to establish an alveolar macrophage cell line model, designated MH-S, for Lp infection and to analyze cytokine responses to Lp infection using this system in comparison with primary alveolar macrophages obtained from mouse alveolar lavage.
| |
Materials and Methods |
|---|
|
|
|---|
Mice
Inbred female Balb/c mice were used for this study. They were purchased from Jackson Laboratories (Bar Harbor, ME) and were 10 to 12 wk of age when used.
Bacteria
Virulent L. pneumophila M124 (Lp-V), serogroup 1, was obtained from a case of fatal legionellosis (19). Avirulent L. pneumophila (Lp-Av) was prepared by multiple passages of M124 as described previously (20). The Lp-Av showed no lethal activity for experimental animals (20). Both Lp-V and Lp-Av were cultured on buffered charcoal yeast extract (BCYE) medium (Gibco Laboratories, Madison, WI) for 3 d at 37°C. The bacteria were suspended in pyrogen-free saline and the bacterial concentration was determined by spectrophotometry.
Macrophages
Two different types of macrophages were used in this study. The MH-S murine alveolar macrophage cell line was purchased from the American Type Culture Collection (Manassas, VA). The cells were maintained in RPMI 1640 medium containing 10% heat- inactivated fetal calf serum (FCS) (Hyclone Laboratories, Logan, UT). The MH-S cells were adhered to 6-well tissue culture plates at a concentration of 5 × 105 cells/ml for 2 h in 5% CO2 at 37°C. Primary alveolar macrophages were obtained as previously described by repeated bronchoalveolar lavage with phosphate-buffered saline (Sigma Chemical Co., St. Louis, MO) containing 5 mM ethylenediaminetetraacetic acid (18). The collected cells were washed three times with Hanks' balanced salt solution (HBSS) by centrifugation and were resuspended in RPMI 1640 medium containing 10% FCS and antibiotics (50 µg of polymyxin B per ml and 50 µg of vancomycin per ml). The primary alveolar macrophages were adhered to 24-well tissue culture plates at a concentration of 5 × 105 cells/ml for 24 h in 5% CO2 at 37oC. All resulting cell monolayers were washed with HBSS, supplied with 10% FCS-RPMI 1640 medium without antibiotics, and then used for experiments.
Infection and Stimulation
The cell monolayers were infected with Lp (infectivity ratio, 10 bacteria per cell) for 30 min, washed to remove nonphagocytized bacteria, and incubated in RPMI 1640 medium containing 10% FCS with no antibiotics. In some experiments, cells were stimulated with 1 µg/ml Escherichia coli lipopolysaccharides (LPS) (Sigma). The cultures were then incubated for up to 48 h at 37°C in 5% CO2.
Viable Bacteria in Cell Cultures (CFU Assay)
The number of viable bacteria (colony-forming unit [CFU]) in cell lysates was determined by standard plate counts on BCYE medium, as described previously (19). After incubation, the cell monolayers were lysed with 0.1% saponin and the number of viable bacteria in the lysates was determined.
Microscopic Examination
The cell monolayers on a glass coverslip were fixed in methanol, stained with diluted Giemsa solution (Sigma), and examined with a microscope (BH-2; Olympus Co., Tokyo, Japan).
Reverse Transcriptase/Polymerase Chain Reaction
RNA isolation from MH-S cells infected with or without Lp was
performed as described previously (18). Total RNA was extracted from cells by either the single-step method with TRI-reagent
(Molecular Research Center, Cincinnati, OH) or the microspin
technique with RNeasy mini kit (Qiagen, Valencia, CA) in accordance with the manufacturer's manual. Reverse transcription (RT)
of total RNA (1 µg) was performed with avian myeloblastosis virus transcriptase in a commercial reaction mixture (Reverse Transcription System; Promega, Madison, WI). The resulting complementary DNA was subjected to polymerase chain reaction (PCR)
with primers for
2-microglobulin (BMG), IL-1
, IL-6, IL-10,
TNF-
, IL-12 p35, and IL-12 p40. The primer sequences for
BMG, IL-1
, IL-6, IL-10, and TNF-
were described previously
(18, 21). The sequences of primer for IL-12 p35 were 5'-AAG
ACA TCA CAC GGG ACC AAA CCA-3' (sense) and 5'-CGC AGA GTC TCG CCA TTA TGA TTC-3' (antisense). The sequences of primer for IL-12 p40 were 5'-CCA CTC ACA TCT
GCT GCT CCA CAA G-3' (sense) and 5'-ACT TCT CAT AGT
CCT TTG GTC CAG-3' (antisense). The PCR was performed in
a Minicycler (MJ Research, Watertown, MS) for either 25 cycles
and 60°C annealing temperature (BMG), 30 cycles and 60°C annealing temperature (IL-1
, IL-6, IL-10, TNF-
), or 40 cycles
and 62°C annealing temperature (IL-12 p35 and IL-12 p40). PCR
products were analyzed on ethidium bromide-stained 2% agarose gels, semiquantitated, and normalized to BMG using densitometry readings (Bio-Rad Laboratories, Hercules, CA).
Enzyme-Linked Immunosorbent Assay
The amount of IL-1
and IL-12 p40/p70 in culture supernatants
was determined by sandwich enzyme-linked immunosorbent assay (ELISA) using antimouse IL-12 p40 and biotin-labeled anti-
IL-12 p40/p70 monoclonal antibodies for IL-12 (PharMingen,
San Diego, CA), and antimouse IL-1
and alkaline phosphatase-
labeled goat antirabbit immunoglobulin antibodies for IL-1
(Genzyme Diagnostics, Cambridge, MA), respectively, in accordance
with the manufacturer's manual.
Statistical Analysis
Statistical analysis was performed with the paired Student's t test.
| |
Results |
|---|
|
|
|---|
Lp Growth in MH-S Alveolar Macrophages and Primary Alveolar Macrophages
To determine the extent that the murine alveolar macrophage cell line and the primary alveolar macrophages could support the growth of Lp, both macrophage types were infected with a 10:1 (bacteria:cell) ratio of either Lp-V or Lp-Av bacteria and assayed for CFU at 6, 24, and 48 h after infection. As evident in Figure 1, both MH-S murine alveolar macrophages (Figure 1A) and primary alveolar macrophages (Figure 1B) were permissive for growth of Lp-V, even though these cells were derived from Balb/c mice, which are resistant to Lp infection and their peritoneal macrophages are nonpermissive for growth of Lp (22). The extent of permissiveness to Lp growth in MH-S cells was comparable with primary alveolar macrophages as well as A/J mouse peritoneal macrophages (22), human alveolar macrophages (12), and rat alveolar macrophages (13), with more than 2 logs multiplication within 2 d. The Lp-Av, on the other hand, was able to survive within the cells but incapable of replication. Microscopic analysis of Lp-infected MH-S cells supported the evidence of multiplication of bacteria in the MH-S cells determined by CFU assay (Figure 2). A few bacteria in a cell were observed at the early infection stage, such as 6 h after infection, but obviously multiplied at 24 h after infection as demonstrated by evidence of many bacteria in a cell.
|
|
Cytokine Messenger RNA Expression of Lp-Infected MH-S Alveolar Macrophages and Primary Alveolar Macrophages
The cytokine expression profile of MH-S cells and primary
alveolar macrophages in response to infection with either
Lp-V or Lp-Av was examined for determination of the
immune response of these cells to Lp infection. When the
MH-S cells were infected with Lp-V, the expression levels
of messenger RNA (mRNA) for IL-1
, IL-6, IL-10, and
TNF-
increased at 6 h after infection (Figure 3), but the
expression level of mRNA for IL-12 did not (data not shown). In order to quantify the message expression, the
relative expression levels of IL-1
, IL-12 p35, and IL-12 p40
messages to the endogenous housekeeping gene BMG
were measured in both macrophage types. As a control for
induction of cytokines, E. coli LPS was used. As evident in
Figures 4 and 5, IL-1
and IL-12 p40 messages tested were
significantly induced by LPS stimulation, showing that both
macrophage types were satisfactory regarding cytokine responses. Furthermore, the expression level of mRNA for
the cytokine responses of MH-S alveolar macrophages to
Lp infection appeared similar to that of primary alveolar
macrophages. When the cells were infected with Lp-V, the
expression levels of mRNA for IL-1
significantly increased at 6 h after infection and decreased after that. In
the case of Lp-Av, the expression level of mRNA for IL-1
was slightly increased at 6 h after infection, followed by
a decrease in both macrophage types (Figure 4). IL-12 p40
message levels were significantly increased at 24 h after infection with Lp-V but not at 6 h (Figure 5). As a control,
LPS stimulation induced a significant increase at this early
time point. However, the levels of IL-12 p40 message in Lp-Av-infected cells showed no significant increase in both
macrophage types. On the other hand, IL-12 p35 message,
which is known to be expressed in various cells constitutively (23), was consistent through the infection (Figure 6).
|
|
|
|
IL-12 p40/p70 and IL-1
Protein Production in
Lp-Infected MH-S Alveolar Macrophages and
Primary Alveolar Macrophages
At the protein level, both Lp-V and Lp-Av infection resulted in only minimum production of IL-12 p40/p70 protein at 24 h after infection in both macrophage types (Figures 7A and 7B). However, the IL-1
protein levels in the
culture supernatants were increased in Lp-V-infected macrophages at 24 h after infection in both macrophage types
(Figures 7C and 7D). In contrast, both IL-12 p40/p70 and IL-1
protein production in both macrophage types stimulated with LPS were significantly increased at 24 h after
stimulation.
|
| |
Discussion |
|---|
|
|
|---|
The results obtained in this study support the usefulness of MH-S cells for in vitro study of Lp infection. The extent of Lp growth in MH-S cells was comparable with primary alveolar macrophages as well as human alveolar macrophages (12) and rat alveolar macrophages (13). Our previous studies showed that peritoneal macrophages from Balb/c mice were nonpermissive for growth of Lp and Balb/c mice were resistant to Lp when infected intraperitoneally (22). The permissiveness of MH-S cells and Balb/c primary alveolar macrophages for Lp, therefore, may indicate that alveolar macrophages could be more susceptible than peritoneal macrophages in regard to Lp infection.
The cytokine response of MH-S alveolar macrophages
to Lp infection was also comparable with primary alveolar
macrophages as well as the findings of some previous reports that showed the induction of cytokines, including IL-1,
IL-6, and TNF-
, in either peritoneal macrophages or macrophage-like cell lines, which were not derived from the
lung, by Lp (6, 24). Therefore, the cytokine response of
MH-S alveolar macrophages to Lp infection appears to be
similar to previously reported in vitro responses.
The study of IL-12 induction in MH-S alveolar macrophages by virulent versus avirulent Lp infection revealed a
differential response of macrophages to this bacterial infection. That is, the messages for IL-12 p40, which is inducible by microbial stimulation whereas IL-12 p35 is synthesized constitutively (23), were slowly but significantly
induced by Lp-V. However, IL-12 protein secretion was
not significantly induced by Lp infection even 24 h after infection. Lp-Av infection did not induce either message
or protein secretion of IL-12. In contrast, IL-1
protein secretion was readily induced by Lp-V but not by Lp-Av.
These results indicate that Lp-V infection can induce the
message for IL-12 p40 in macrophages, but production of
IL-12 protein may be inhibited for some reason in Lp-V-
infected macrophages by an unknown mechanism. This inhibition was specific for IL-12 because both IL-1
message
and protein secretion as well as other cytokine messages,
such as IL-6, IL-10, and TNF-
, in Lp-V-infected macrophages were readily induced by infection. Although the
mechanism of inhibition was not clear, current studies
suggest there is an active inhibition mechanism for IL-12
production after Lp infection because LPS-induced IL-12 production could be selectively inhibited by Lp infection
(unpublished observation). The weaker or minimum induction of cytokines, including IL-12 in Lp-Av-infected cells,
may be due to the lack of growth of avirulent bacteria in
the macrophages.
Thus, the MH-S alveolar macrophage cell line can be a useful in vitro model system to study Lp infection. Furthermore, the study indicates that virulent Lp infection of alveolar macrophages induces minimum production of IL-12, which is critical for the development of the Th1 phenotype even though other cytokines are markedly induced.
| |
Footnotes |
|---|
Address correspondence to: Yoshimasa Yamamoto, Ph.D., Dept. of Medical Microbiology and Immunology, University of South Florida College of Medicine, 12901 Bruce B. Downs Blvd., Tampa, FL 33612. E-mail: yyamamot{at}com1.med.usf.edu
(Received in original form September 1, 2000 and in revised form November 13, 2000).
Acknowledgments: The authors thank Catherine Newton for technical assistance. This work was supported by grant AI45169 from the National Institute of Allergy and Infectious Diseases and by a grant from the American Lung Association of Florida.
Abbreviations
buffered charcoal yeast extract, BCYE;
2-microglobulin, BMG;
colony-forming unit, CFU;
cell-mediated immunity, CMI;
enzyme-linked immunosorbent assay, ELISA;
fetal calf serum, FCS;
Hanks' balanced salt solution, HBSS;
interferon-gamma, IFN-
;
interleukin, IL;
tumor
necrosis factor-
, TNF-
;
Legionella pneumophila, Lp;
Avirulent Legionella
pneumophila, Lp-Av;
virulent Legionella pneumophila, Lp-V;
lipopolysaccharide, LPS;
messenger RNA, mRNA;
reverse transcriptase/polymerase
chain reaction, RT-PCR;
standard deviation, SD;
T helper 1, Th1.
| |
References |
|---|
|
|
|---|
1. Winn, W. C. Jr., and R. L. Myerowitz. 1981. The pathology of the Legionella pneumosis. Hum. Pathol. 12: 401-422 [Medline].
2.
Hsieh, C.-S.,
S. E. Macatonia,
C. S. Tripp,
S. F. Wolf,
A. O'Garra, and
K. M. Murphy.
1993.
Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.
Science
260:
547-549
3.
Nash, T. W.,
D. M. Libby, and
D. M. Horwitz.
1988.
IFN-
-activated human
alveolar macrophages inhibit the intracellular multiplication of Legionella
pneumophila.
J. Immunol.
140:
3978-3981
[Abstract].
4.
Bhardwaj, N.,
T. W. Nash, and
D. M. Horwitz.
1986.
IFN-
-activated human
monocytes inhibit the intracellular multiplication of Legionella pneumophila.
J. Immunol.
137:
2662-2669
[Abstract].
5.
Park, D. R., and
S. J. Skerrett.
1996.
IL-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the
protective effect of IFN-
.
J. Immunol.
157:
2528-2538
[Abstract].
6. Klein, T. W., C. A. Newton, K. Blanchard, R. Widen, and H. Friedman. 1987. Induction of interleukin 1 by Legionella pneumophila antigens in mouse macrophage and human mononuclear leukocyte cultures. Zentralbl. Bakteriol. Hyg. Microbiol. A265:462-471.
7. Widen, R., T. W. Klein, C. A. Newton, and H. Friedman. 1989. Induction of interleukin 1 by Legionella pneumophila in murine peritoneal macrophage cultures. Proc. Soc. Exp. Biol. Med. 191: 304-308 [Abstract].
8.
Yamamoto, Y.,
S. Okubo,
T. W. Klein,
K. Onozaki,
T. Saito, and
H. Friedman.
1994.
Binding of Legionella pneumophila to macrophages increases
cellular cytokine mRNA.
Infect. Immun.
62:
3947-3956
9.
Skerrett, S. J.,
G. J. Bagby,
R. A. Schmidt, and
S. Nelson.
1997.
Antibody-mediated depleton of tumor necrosis factor-
impairs pulmonary host defenses to Legionella pneumophila.
J. Infect. Dis.
176:
1019-1028
[Medline].
10. Caignard, A., M. S. Martin, A. Hammann, and F. Marlin. 1985. Heterogeneity of the rat macrophage: antigenic specificity of resident peritoneal and pleural macrophages. Cell. Mol. Biol. 31: 41-47 [Medline].
11. Spiteri, M. A., S. W. Clark, and L. W. Poulter. 1992. Isolation of phenotypically and functionally distinct macrophage subpopulations from human bronchoalveolar lavage. Eur. Respir. J. 5: 717-726 [Abstract].
12. Nash, T. W., D. M. Libby, and M. A. Horwitz. 1984. Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages: influence of antibody, lymphokine, and hydrocortisone. J. Clin. Invest. 74: 771-782 .
13. Skerrett, S. J., and T. R. Martin. 1991. Alveolar macrophage activation in experimental legionellosis. J. Immunol. 147: 337-345 [Abstract].
14. Mbawukie, I. N., and B. H. Herbert. 1989. MH-S, a murine alveolar macrophage cell line: morphological, cytochemical, and functional characteristics. J. Leukoc. Biol. 46: 119-127 [Abstract].
15. Sankaran, K., and H. B. Herscowitz. 1995. Phenotypic and functional heterogeneity of the murine alveolar macrophage-derived cell line MH-S. J. Leukoc. Biol. 57: 562-568 [Abstract].
16. Hearst, J. E., G. A. Warr, and G. J. Jakab. 1980. Characterization of murine lung and peritoneal macrophages. J. Reticuloendothel. Soc. 27: 443-454 [Medline].
17. Simon, L. M., E. D. Robin, J. R. Phillips, J. Acevedo, S. Axline, and J. Theodore. 1977. Enzyme basis for bioenergetic differences of alveolar versus peritoneal macrophages and enzyme regulation by molecular O2. J. Clin. Invest. 59: 443-448 .
18. Yamamoto, Y., C. Retzlaff, P. He, T. W. Klein, and H. Friedman. 1995. Quantitative reverse transcription-PCR analysis of Legionella pneumophila-induced cytokine mRNA in different macrophage populations by high-performance liquid chromatography. Clin. Diag. Lab. Immunol. 2: 18-24 [Abstract].
19.
Friedman, H.,
R. Widen,
T. W. Klein,
L. Searls, and
K. Cabrian.
1984.
Legionella pneumophila-induced blastogenesis of murine lymphoid cells in
vitro.
Infect. Immun.
43:
314-319
20. Yamamoto, Y., T. W. Klein, and H. Friedman. 1993. Legionella pneumophila virulence conserved after multiple single-colony passage on agar. Curr. Microbiol. 27: 241-245 .
21. Ehlers, S., M. E. Mielke, T. Blankenstein, and H. Hahn. 1992. Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes: the immediate early phase in innate resistance and acquired immunity. J. Immunol. 149: 3016-3022 [Abstract].
22.
Yamamoto, Y.,
T. W. Klein,
C. A. Newton,
R. Widen, and
H. Friedman.
1988.
Growth of Legionella pneumophila in thioglycollate-elicited peritoneal macrophages from A/J mice.
Infect. Immun.
56:
370-375
23.
D'Andrea, A.,
M. Rengaraju,
N. M. Valiante,
J. Chemini,
M. Kubin,
M. Aste,
S. H. Chan,
M. Kobayashi,
D. Young,
E. Nickberg,
R. Chizzonite,
S.
F. Wolf, and
G. Trinchieri.
1992.
Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells.
J. Exp.
Med.
176:
1387-1398
24. Neumeister, B., A. Kleihauer, V. Rossmann, E. Fehrenbach, M. Faigle, S. Baumbach, and H. Northoff. 1998. Induction of cytokines and expression of surface receptors in Mono Mac 6 cells after infection with different Legionella species. APMIS 106: 319-333 [Medline].
This article has been cited by other articles:
![]() |
P. Bandyopadhyay, S. Liu, C. B. Gabbai, Z. Venitelli, and H. M. Steinman Environmental Mimics and the Lvh Type IVA Secretion System Contribute to Virulence-Related Phenotypes of Legionella pneumophila Infect. Immun., February 1, 2007; 75(2): 723 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dubourdeau, R. Athman, V. Balloy, M. Huerre, M. Chignard, D. J. Philpott, J.-P. Latge, and O. Ibrahim-Granet Aspergillus fumigatus Induces Innate Immune Responses in Alveolar Macrophages through the MAPK Pathway Independently of TLR2 and TLR4 J. Immunol., September 15, 2006; 177(6): 3994 - 4001. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L McNealy, V. Forsbach-Birk, C. Shi, and R. Marre The Hfq Homolog in Legionella pneumophila Demonstrates Regulation by LetA and RpoS and Interacts with the Global Regulator CsrA J. Bacteriol., February 15, 2005; 187(4): 1527 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okamoto, K. Gohil, E. I. Finkelstein, P. Bove, T. Akaike, and A. van der Vliet Multiple contributing roles for NOS2 in LPS-induced acute airway inflammation in mice Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L198 - L209. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsunaga, H. Yamaguchi, T. W. Klein, H. Friedman, and Y. Yamamoto Legionella pneumophila Suppresses Macrophage Interleukin-12 Production by Activating the p42/44 Mitogen-Activated Protein Kinase Cascade Infect. Immun., November 1, 2003; 71(11): 6672 - 6675. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ibrahim-Granet, B. Philippe, H. Boleti, E. Boisvieux-Ulrich, D. Grenet, M. Stern, and J. P. Latge Phagocytosis and Intracellular Fate of Aspergillus fumigatus Conidia in Alveolar Macrophages Infect. Immun., February 1, 2003; 71(2): 891 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsunaga, T. W. Klein, H. Friedman, and Y. Yamamoto Epigallocatechin Gallate, a Potential Immunomodulatory Agent of Tea Components, Diminishes Cigarette Smoke Condensate-Induced Suppression of Anti-Legionella pneumophila Activity and Cytokine Responses of Alveolar Macrophages Clin. Vaccine Immunol., July 1, 2002; 9(4): 864 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsunaga, T. W. Klein, H. Friedman, and Y. Yamamoto Involvement of Nicotinic Acetylcholine Receptors in Suppression of Antimicrobial Activity and Cytokine Responses of Alveolar Macrophages to Legionella pneumophila Infection by Nicotine J. Immunol., December 1, 2001; 167(11): 6518 - 6524. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsunaga, T. W. Klein, H. Friedman, and Y. Yamamoto Legionella pneumophila Replication in Macrophages Inhibited by Selective Immunomodulatory Effects on Cytokine Formation by Epigallocatechin Gallate, a Major Form of Tea Catechins Infect. Immun., June 1, 2001; 69(6): 3947 - 3953. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |